Nuvectis Pharma (NVCT) Institutional Ownership $9.75 -0.21 (-2.11%) As of 01:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)CurrentInstitutional OwnershipPercentage96.77%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$6.00MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$378.54K Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NVCT Institutional Buying and Selling by Quarter Nuvectis Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/1/2025Austin Wealth Management LLC40,250$393K0.1%N/A0.172% 4/30/2025Iridian Asset Management LLC CT253,972$2.48M0.8%N/A1.086% 4/23/2025 Oppenheimer & Co. Inc.41,000$401K0.0%+64.0%0.175% 4/14/2025 Baldwin Wealth Partners LLC MA358,461$3.50M0.2%+0.7%1.532% 4/11/2025 Blue Zone Wealth Advisors LLC10,424$102K0.0%N/A0.045% 2/17/2025Squarepoint Ops LLC19,071$103K0.0%N/A0.099% 2/17/2025Two Sigma Investments LP18,570$100K0.0%-30.7%0.096% 2/17/2025Millennium Management LLC29,698$161K0.0%-56.6%0.154% 2/17/2025Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033% 2/14/2025Northern Trust Corp25,725$139K0.0%+68.7%0.133% Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025Marshall Wace LLP124,571$674K0.0%+191.0%0.645% 2/12/2025Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079% 2/12/2025 Baxter Bros Inc.15,000$81K0.0%+20.0%0.078% 2/5/2025 Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129% 1/30/2025Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070% 1/28/2025Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305% 1/22/2025 Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842% 11/16/2024Geode Capital Management LLC79,716$501K0.0%+49.8%0.413% 11/5/2024GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269% 11/5/2024Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054% 10/25/2024Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297% 9/16/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/15/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/14/2024Marshall Wace LLP33,868$214K0.0%-32.4%0.185% 8/9/2024Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406% 7/16/2024 Baxter Bros Inc.12,500$79K0.0%N/A0.068% 7/12/2024 Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918% 5/10/2024Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626% 4/18/2024 Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081% 2/12/2024Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111% 1/30/2024Strs Ohio6,200$51K0.0%+59.0%0.036% 1/8/2024 Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820% 11/2/2023Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197% 10/26/2023Strs Ohio3,900$50K0.0%+178.6%0.023% 10/10/2023 Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675% 8/10/2023Hollencrest Capital Management3,040$49K0.0%N/A0.019% 8/4/2023American International Group Inc.3,298$53K0.0%N/A0.021% 8/3/2023Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418% 8/2/2023Bank of Montreal Can11,012$200K0.0%N/A0.069% 7/14/2023 Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563% Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source5/11/2023Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167% 4/21/2023 Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975% 11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843% 10/14/2022 Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908% 8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297% 7/18/2022 Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951% 5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325% (Data available from 1/1/2016 forward) NVCT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVCT shares? During the previous two years, 25 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Baldwin Wealth Partners LLC MA ($3.50M), Iridian Asset Management LLC CT ($2.48M), Vanguard Group Inc. ($2.45M), Baldwin Brothers LLC MA ($1.07M), Marshall Wace LLP ($674K), Geode Capital Management LLC ($501K), and Renaissance Technologies LLC ($472K).Learn more on NVCT's institutional investors. What percentage of Nuvectis Pharma stock is owned by institutional investors? 96.77% of Nuvectis Pharma stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings. Which institutional investors have been buying Nuvectis Pharma stock? Of the 23 institutional investors that purchased Nuvectis Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Iridian Asset Management LLC CT ($309.35K), Baldwin Wealth Partners LLC MA ($184.33K), Marshall Wace LLP ($81.76K), Forbes J M & Co. LLP ($77.60K), Baldwin Brothers LLC MA ($66.48K), Edmond DE Rothschild Holding S.A. ($43.74K), and Oppenheimer & Co. Inc. ($41K). How much institutional buying is happening at Nuvectis Pharma? Institutional investors have bought a total of 1,019,771 shares in the last 24 months. This purchase volume represents approximately $8.55M in transactions. Which Nuvectis Pharma major shareholders have been selling company stock? The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Baldwin Brothers LLC MA ($53.74K), Millennium Management LLC ($38.80K), Forbes J M & Co. LLP ($33K), Marshall Wace LLP ($16.20K), Two Sigma Investments LP ($8.22K), and Edmond DE Rothschild Holding S.A. ($4K). How much institutional selling is happening at Nuvectis Pharma? Institutional investors have sold a total of 153,955 shares in the last 24 months. This volume of shares sold represents approximately $1.66M in transactions. Related Companies VIR Major Shareholders AVDL Major Shareholders RCKT Major Shareholders PHVS Major Shareholders XNCR Major Shareholders AVXL Major Shareholders ABCL Major Shareholders DAWN Major Shareholders CVAC Major Shareholders QURE Major Shareholders This page (NASDAQ:NVCT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVCT Stock Free NVCT Stock Alerts